Related Experiment Video
Updated: Jul 19, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
[The immunomodulating and metabolic actions of thymalin in an experimental herpetic infection]
Insights
Thymalin treatment modulated immune and metabolic responses in mice infected with herpes virus type I. This peptide therapy improved phagocytic activity and normalized metabolic shifts, offering a dual therapeutic effect.
Area of Science:
- Immunology
- Virology
- Biochemistry
Background:
- Herpes virus type I (HSV-1) infection can cause significant neurological damage.
- Understanding the immune and metabolic consequences of HSV-1 infection is crucial for developing effective treatments.
- Investigating immunomodulatory agents like thymalin may offer therapeutic benefits.
Purpose of the Study:
- To evaluate the effects of thymalin on immune cell activity and metabolic parameters in mice with experimental HSV-1 infection.
- To assess the immunomodulating and metabolic effects of thymalin treatment.
Main Methods:
- Intracerebral inoculation of herpes virus type I into CBA mice.
- Assessment of phagocytic activity of peritoneal macrophages and leukocyte migration.
- Measurement of enzyme activity in gluconeogenesis and lipid peroxidation in liver tissue.
- Analysis of blood glucose and glycosylated hemoglobin levels.
- Histological examination of brain and internal organs.
- Comparison between thymalin-treated and untreated groups.
Main Results:
- HSV-1 infection led to suppressed phagocytic activity and reduced leukocyte response to phytohemagglutinin (PHA).
- Metabolic disturbances, including shifts in gluconeogenesis and lipid peroxidation in liver tissue, were observed.
- Thymalin treatment demonstrated a combined immunomodulating effect by enhancing phagocytic activity and leukocyte response.
- Thymalin also exhibited a metabolic effect, counteracting some of the infection-induced biochemical alterations.
Conclusions:
- Thymalin possesses both immunomodulating and metabolic properties beneficial in managing experimental herpes virus type I infection.
- The findings suggest thymalin as a potential therapeutic agent for infections involving immune and metabolic dysregulation.
Abstract:
In experiments on the intracerebral inoculation of herpes virus, type I, into 38 CBA mice the phagocytic activity of peritoneal exudate, cells, spontaneous migration of leukocytes and their response to phytohemagglutinin (PHA), the activity of key enzymes of gluconeogenesis, lipid peroxidation in liver tissue, as well as the level of glucose and glycosylated hemoglobin in the blood, were determined simultaneously with the histological study of the brain and the main internal organs of the animals, receiving thymalin treatment and not receiving it. As demonstrated in these experiments, the development of experimental infection was accompanied by the inhibition of the phagocytic activity of peritoneal macrophages and response of leukocytes to PHA, as well as metabolic shifts in liver tissue. Treatment with thymalin produced a combined immunomodulating and metabolic effect.
Related Concept Videos
Cell-mediated Immune Responses
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis

